Stocktoria
Glucotrack, Inc. GCTK
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2013-04-09
Glucotrack, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| R&D expense | $9.8M | $9.5M | $4.7M | $2.0M | $1.8M |
| SG&A expense | — | — | — | — | $139,000 |
| Operating income | -$16.1M | -$14.5M | -$7.1M | -$4.4M | -$4.0M |
| Interest expense | — | $44,000 | — | — | — |
| Net income | -$19.4M | -$22.6M | -$7.1M | -$4.4M | -$4.1M |
| EPS (diluted) | $31.22 | $4106.00 | $34.18 | $0.29 | $0.26 |
| Operating cash flow | -$15.2M | -$12.5M | -$6.6M | -$3.7M | -$3.8M |
| Free cash flow | -$15.3M | -$12.6M | — | -$3.7M | -$3.8M |
| Cash & equivalents | $7.4M | $5.6M | $4.5M | $2.3M | $6.1M |
| Total assets | $7.8M | $5.9M | $4.9M | $2.4M | $6.3M |
| Total liabilities | $5.0M | $18.9M | $1.7M | $1.2M | $1.1M |
| Shareholders' equity | $2.8M | -$13.0M | $3.2M | $1.2M | $5.2M |
Source: SEC EDGAR filings · CIK 0001506983 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.